We are live on ! Find out more
NVNOW

enVVeno Medical Corporation Warrants
NVNOW

Delisted

NVNOW was delisted on the 26th of May, 2023.

Back to rankings

1 hedge funds and large institutions have $2K invested in enVVeno Medical Corporation Warrants in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

33% less capital invested

Capital invested by funds: $3K → $2K (-$1K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$2K – – –

NVNOW Hedge Fund Activity: Q2 2019 in Review

1 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q2 2019, worth a combined $2K — down 33% from $3K a quarter earlier.

Fund positioning in NVNOW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held enVVeno Medical Corporation Warrants (NVNOW) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $2K of enVVeno Medical Corporation Warrants stock for Q2 2019, down 33% quarter-over-quarter.
  • 0 funds opened new enVVeno Medical Corporation Warrants positions in Q2 2019 and 0 closed out.

Based on aggregated 13F filings for Q2 2019.